These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3629484)

  • 1. [Amino acid composition of the blood in patients with diffuse toxic goiter during conservative therapy].
    Borodina LV
    Ter Arkh; 1987; 59(6):100-3. PubMed ID: 3629484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].
    Matiashina GI
    Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Content of free amino acids in the blood serum in patients with toxic goiter].
    KorvatskiÄ­ BG; Stepanenko AP; Nozdrachev SI
    Sov Med; 1973 Dec; 36(12):65-8. PubMed ID: 4801390
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
    Iangolenko VV
    Ter Arkh; 1991; 63(10):60-3. PubMed ID: 1725225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune thrombocytopenia and diffuse-toxic goiter].
    Mogucheva EI; Idel'son LI; Granovskaia-Tsvetkova AM; Romashov FN; Alekseev GI
    Ter Arkh; 1985; 57(7):79-84. PubMed ID: 3840284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience using lithium carbonate in the complex treatment of diffuse toxic goiter].
    Petrov NM
    Ter Arkh; 1985; 57(12):32-6. PubMed ID: 3937256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The determination of natural killer cells in the peripheral blood of patients with diffuse toxic goiter].
    Podil'chak MD; Terletskaia LM; Kun ND
    Vrach Delo; 1990 May; (5):51-2. PubMed ID: 2396392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The characteristics of craniocerebral trauma in diffuse toxic goiter].
    Pedachenko EG
    Zh Vopr Neirokhir Im N N Burdenko; 1992; (1):10-1. PubMed ID: 1316693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lithium carbonate in the treatment of patients with diffuse toxic goiter].
    Petrov NM
    Vrach Delo; 1986 Jun; (6):64-6. PubMed ID: 3092467
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE
    Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acid mucopolysaccharide content of the blood in patients with diffuse toxic goiter and ophthalmopathy].
    OleÄ­nik VA; Kamenetskaia MS
    Vrach Delo; 1988 Jul; (7):70-2. PubMed ID: 2973180
    [No Abstract]   [Full Text] [Related]  

  • 12. [Free amino acid spectrum and cathepsin activity in the blood serum of patients with diabetes mellitus combined with diffuse toxic goiter].
    Grigor'eva LP; Stroev EA; Dubinina II
    Probl Endokrinol (Mosk); 1982; 28(3):13-6. PubMed ID: 6896578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood levels of parathyroid hormone, calcitonin, calcium and magnesium in patients with diffuse toxic goiter].
    Mosin VI; Borodina LV
    Ter Arkh; 1981; 53(11):112-4. PubMed ID: 6896101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diffuse toxic goiter].
    Dedov II; Mel'nichenko GA; Aleksandrova GF
    Klin Med (Mosk); 1992; 70(5-6):65-70. PubMed ID: 1434409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of glucocorticosteroids on the immunological indices of diffuse toxic goiter patients].
    Epishin AV
    Vrach Delo; 1984 Jul; (7):41-3. PubMed ID: 6332424
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of zymosan and levamisole in the complex treatment of patients with diffuse toxic goiter].
    Epishin AV; Epishina NA
    Ter Arkh; 1986; 58(10):108-12. PubMed ID: 3798334
    [No Abstract]   [Full Text] [Related]  

  • 17. [Copper and ascorbic acid content in the blood of patients with diffuse toxic and different forms of endemic goiter].
    Savina PN
    Sov Med; 1971 Sep; 34(9):148-50. PubMed ID: 5171296
    [No Abstract]   [Full Text] [Related]  

  • 18. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Free amino acid content of blood in patients with ulcer disease depending on the characteristics of clinical course].
    Ilika VG
    Vrach Delo; 1974 Dec; (12):64-9. PubMed ID: 4446537
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies of breast cancer with the antitumor drug Ukrain.
    Nefyodov LI; Uglyanitsa KN; Smirnov VY; Karavay AV; Brzosko W
    Drugs Exp Clin Res; 2000; 26(5-6):231-7. PubMed ID: 11345030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.